D. C. GÜVEN Et Al. , "The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors," Anti-Cancer Drugs , vol.34, no.6, pp.783-790, 2023
GÜVEN, D. C. Et Al. 2023. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. Anti-Cancer Drugs , vol.34, no.6 , 783-790.
GÜVEN, D. C., ÖZBEK, D. A., ŞAHİN, T. K., KAVGACI, G., Aksun, M. S., ERUL, E., ... YILDIRIM, H. Ç.(2023). The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. Anti-Cancer Drugs , vol.34, no.6, 783-790.
GÜVEN, DENİZ Et Al. "The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors," Anti-Cancer Drugs , vol.34, no.6, 783-790, 2023
GÜVEN, DENİZ C. Et Al. "The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors." Anti-Cancer Drugs , vol.34, no.6, pp.783-790, 2023
GÜVEN, D. C. Et Al. (2023) . "The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors." Anti-Cancer Drugs , vol.34, no.6, pp.783-790.
@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors}, journal={Anti-Cancer Drugs}, year=2023, pages={783-790} }